FDA-regulated commodity entries to be made via ACE | KPMG | GLOBAL

FDA-regulated commodity entries to be made via ACE

FDA-regulated commodity entries to be made via ACE

The U.S. Customs and Border Protection (CBP) today released for publication in the Federal Register a general notice announcing that a pilot test program concerning the electronic transmission of certain import data for all FDA-regulated commodities through the Automated Commercial Environment (ACE) is being finalized.


Related content

Today’s release [PDF 194 KB] states that the pilot program has been a success, in that it shows that ACE is capable of accepting FDA-regulated electronic entries. Accordingly, the pilot program is ending. 

CBP’s general notice encourages all importers of merchandise that is regulated by the Food and Drug Administration (FDA) to begin using ACE for their electronic filings. Today’s release further states that at a point in the near future, ACE will be the sole CBP-authorized electronic data interchange system for these filings.

The FDA pilot test will end on 30 days after the publication of today’s release in the Federal Register, which is scheduled for Thursday, March 31, 2016.


For more information, contact a professional with KPMG’s Trade & Customs practice:

Douglas Zuvich | +1 (312) 665-1022 | dzuvich@kpmg.com

Andrew Siciliano | +1 (631) 425-6057 | asiciliano@kpmg.com

© 2018 KPMG LLP, a Delaware limited liability partnership and the U.S. member firm of the KPMG network of independent member firms affiliated with KPMG International Cooperative (“KPMG International”), a Swiss entity. All rights reserved.

The KPMG logo and name are trademarks of KPMG International. KPMG International is a Swiss cooperative that serves as a coordinating entity for a network of independent member firms. KPMG International provides no audit or other client services. Such services are provided solely by member firms in their respective geographic areas. KPMG International and its member firms are legally distinct and separate entities. They are not and nothing contained herein shall be construed to place these entities in the relationship of parents, subsidiaries, agents, partners, or joint venturers. No member firm has any authority (actual, apparent, implied or otherwise) to obligate or bind KPMG International or any member firm in any manner whatsoever. The information contained in herein is of a general nature and is not intended to address the circumstances of any particular individual or entity. Although we endeavor to provide accurate and timely information, there can be no guarantee that such information is accurate as of the date it is received or that it will continue to be accurate in the future. No one should act on such information without appropriate professional advice after a thorough examination of the particular situation. For more information, contact KPMG's Federal Tax Legislative and Regulatory Services Group at: + 1 202 533 4366, 1801 K Street NW, Washington, DC 20006.

Connect with us


Request for proposal